IndraLab

Statements

Erlotinib inhibits RELA. 4 / 4
| 4
reach
"In contrast, erlotinib treatment decreased pERK, pAKT and pRelA and increased the levels of cleaved Parp only upon AXL knockdown in the ER1 and ER2 cell lines (XREF_FIG)."
22751098
reach
"As expected, we found that erlotinib treatment decreased pERK, pAKT and pRelA (a marker of NF-kB signaling) and increased Parp cleavage (a marker of apoptosis) in parental HCC827 cells (XREF_FIG)."
22751098
reach
"Erlotinib treatment for 48h decreased pAKT, pERK, and pRelA and increased Parp cleavage in sensitive tumors (a marker of apoptosis) (XREF_FIG) but pAKT, pERK, pRelA levels were maintained in each tumor with acquired erlotinib resistance (XREF_FIG)."
22751098
reach
"Both erlotinib and EGCG or their combination failed to inhibit p65 and Bcl-2 in M4e cells (XREF_FIG)."
19470788